San Diego-centered Viking Therapeutics marked itself as a serious competitor during the weight loss drug industry in February following revealing promising information from a mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection As well as in March th